In five minutes
ClearGazeTest measures fifteen brain functions through how your eyes move.
Biomarkers
Scenarios
Doors
Platform
Minutes matter.
HINTS+ • ICU • Vertigo
Train safer. Play smarter.
Concussion • Vision • Youth
Measurement informs care.
Senior • Pediatric • Long COVID
Fit for duty. Defensible.
Roadside • Workplace • Fleet
Readiness, every domain.
Drones • Pilots • SOF • TBI
The people. The platform.
Founders • Mission • Varjo XR-4
Fifteen objective neuro-ocular biomarkers across thirty-one instrumented VR scenarios.
Field-deployable in under three minutes. PubMed-verified. Defensible. Same brain. Every domain.
The biomarker is the same. The hardware is the same. The team behind the report is the same. What differs is who asked the question and what they will do with the answer.
From a clinician's tablet or a sergeant's ruggedized laptop, the workflow is identical. Patients, athletes, drivers, and warfighters all run the same protocol - different scenarios, same measurement.
Varjo XR-4 Secure Edition fits over the eyes in under thirty seconds. Calibration is automatic. No technician training required beyond a five-minute orientation.
Choose the scenario aligned with the question - bedside HINTS+, sideline concussion, roadside impairment, drone-operator pre-mission. Eye tracking runs at 200Hz throughout.
Fifteen biomarkers, classified against PubMed-verified norms, presented in a clinician-readable or operationally-actionable report. Plain language. Defensible logic.
Every classification traces back to a specific signal feature and a published normative dataset. No black box. No proprietary mystery. Just the published neurology of the eye, instrumented at 200 hertz, age-adjusted and clinically reportable.
Every operationally important moment runs through the same four-stage decision cycle. ClearGazeTest is the only platform that measures all four stages - not just the action - at the millisecond level.
Fixation onset, saccade target acquisition, peripheral threat detection.
Pattern recognition, prior knowledge integration, contextual situational awareness.
Decision speed, cognitive load, attention allocation under uncertainty.
Motor output to the eye, hand, voice, or controller. The visible behavior.
The brain decides before the trigger finger does. We measure the deciding.
Not dependent on subjective patient responses. Objective signal, every session.
Applicable across age, athletic, civilian, clinical, and military samples.
Supports tracking gradual improvement, persistence, or recovery over time.
The same platform serves bedside, sideline, roadside, and forward operations.
Broader than a single-application device or single-disease test.
In active dialogue with the agencies that fund and field neuro-cognitive measurement.
Every ClearGazeTest session produces a clinician-readable, patient-shareable, and legally-defensible report. No proprietary scoring system. Every number traces back to a PubMed-published norm.
ClearGazeTest is led by Dr. Michael Duplessie (FRCS Ophth, Glasgow), who conducted the first LASIK course taught in the United States in 1996 and trained in the David G. Cogan neuro-ophthalmology lineage at the National Eye Institute. Every biomarker we measure is one Cogan, his students, or the field has been studying for decades - instrumented now in VR at 200 hertz, on hardware that fits in a briefcase.
We are in active conversation with academic departments of neurology, ophthalmology, neuro-ophthalmology, rehabilitation, and emergency medicine at major medical centers across the United States. We will name our clinical collaborators publicly when their participation is formally agreed.
The platform is federally funded at the proposal stage under DARPA DSO, AFWERX, the Navy SBIR program, and NIBIB, and is being evaluated for clinical, athletic, occupational, and operational applications by buyers in each of the six audience doors.
The eye is the most accessible part of the brain. ClearGazeTest is the most rigorous reading of it we have today - across every population that needs it.
Dr. Michael Duplessie, FRCS Ophth (Glasgow)
Different audiences need different conversations. Pick the door that fits and we will meet you there.
CLINICIANS
Twenty-minute demonstration. We will show you the workflow, the report templates, and the biomarker library - and answer the integration questions your IT team will ask.
REQUEST A DEMO →DOD & FEDERAL
For program offices in DARPA, AFWERX, ONR, the JCO, and Service Component Commands evaluating drone-operator readiness, Counter-UAS, or warfighter TBI.
START THE CONVERSATION →INVESTORS
Series Seed scoping for late 2026. Funding atlas across NIH, NSF, DoD, philanthropic, and corporate strategic across all six doors.
REQUEST DECK →MEDIA & PARTNERS
Press inquiries, partnership discussions with platforms (Varjo, Smart Eye/iMotions, simulation contractors), and academic collaborator outreach.
REACH OUT →"Same brain. Same biomarker. Every domain."
THE CLEARGAZETEST MANTRA
